Market News AIOpen the app

HRTX stock news · Heron Therapeutics, Inc.

Stories about Heron Therapeutics, Inc. (HRTX) from the last 90 days, each explained in plain English with whether the news reads good or bad for the company.

Get alerts for HRTX

Follow Heron Therapeutics, Inc. (HRTX) free. When we publish a story about it, you get the plain-English explanation as an alert.

Get alerts for HRTX
Free on the App Store and Google Play, or on the web.
  1. Nov 9, 2026, 8:20 AM ET · Market

    Heron Therapeutics shared its financial results for the third quarter of 2026.

    Neutral

    Heron filed a report announcing results for the 3 and 9 months ended September 30, 2026, but gave no figures. This does not show whether its business improved or worsened.

  2. Nov 9, 2026, 7:47 AM ET · Market

    Heron Therapeutics is selling most of its assets to CorMedix for cash, stock, and future payments based on sales.

    Neutral

    Heron agreed to sell most assets for $145 million and 14.6 million CorMedix shares, plus possible payments. Debt repayment helps, but lost assets and an unknown plan leave its outlook balanced.